These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25726571)

  • 21. Albendazole for mass drug administration to eliminate lymphatic filariasis.
    Sabesan S
    Lancet Infect Dis; 2006 Nov; 6(11):684-5. PubMed ID: 17067916
    [No Abstract]   [Full Text] [Related]  

  • 22. Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration.
    Chandrasena NT; Premaratna R; Samarasekera DS; de Silva NR
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):620-622. PubMed ID: 27816936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic filariasis in Peninsular Malaysia: a cross-sectional survey of the knowledge, attitudes, and practices of residents.
    Al-Abd NM; Nor ZM; Ahmed A; Al-Adhroey AH; Mansor M; Kassim M
    Parasit Vectors; 2014 Nov; 7():545. PubMed ID: 25428558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
    Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
    Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
    De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
    Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline drivers of lymphatic filariasis in Burkina Faso.
    Stanton MC; Molyneux DH; Kyelem D; Bougma RW; Koudou BG; Kelly-Hope LA
    Geospat Health; 2013 Nov; 8(1):159-73. PubMed ID: 24258892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia.
    Titaley CR; Damayanti R; Soeharno N; Mu'asyaroh A; Bradley M; Lynam T; Krentel A
    Parasit Vectors; 2018 May; 11(1):315. PubMed ID: 29801511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
    Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
    PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National mass drug administration costs for lymphatic filariasis elimination.
    Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
    Mani TR; Rajendran R; Sunish IP; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2004 Sep; 9(9):1030-5. PubMed ID: 15361118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration.
    Cabral S; Bonfim C; Oliveira R; Oliveira P; Guimarães T; Brandão E; Aguiar-Santos AM; Medeiros Z
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e23. PubMed ID: 28443941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
    Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
    Cantey PT; Rao G; Rout J; Fox LM
    Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of MDA and the prospects of elimination of the lone focus of diurnally sub periodic lymphatic filariasis in Nicobar Islands, India.
    Shriram AN; Krishnamoorthy K; Sivan A; Saha BP; Kumaraswami V; Vijayachari P
    Acta Trop; 2014 May; 133():93-7. PubMed ID: 24556139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone.
    Hodges MH; Sonnie M; Turay H; Conteh A; Maccarthy F; Sesay S
    Parasit Vectors; 2012 Oct; 5():232. PubMed ID: 23062561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.